Literature DB >> 7323136

HPLC determination of antipyrine metabolites.

M Eichelbaum, B Sonntag, H J Dengler.   

Abstract

A high-performance liquid chromatography method is described which allows for the simultaneous determination of antipyrine, 4-hydroxyantipyrine, norantipyrine and 3-hydroxyantipyrine. Hydrolysis conditions with respect to source glucuronidase, amount of glucuronidase, pH of incubation and addition of antioxidant to the incubation medium proved to be very critical for norantipyrine and to a lesser extent 4-hydroxyantipyrine. The method is of good sensitivity, accuracy and reproducibility. Thus, the method is well suited for detailed metabolic studies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7323136     DOI: 10.1159/000137550

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  14 in total

1.  Disposition of antipyrine in patients with extensive metastatic liver disease.

Authors:  G M Robertz-Vaupel; K D Lindecken; T Edeki; C Funke; S Belwon; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.

Authors:  E Perucca; R Grimaldi; G M Frigo; A Sardi; H Mönig; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Biliary excretion of antipyrine and its metabolites after cholecystectomy.

Authors:  H Mönig; J Wilhelmy; S John; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

4.  Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.

Authors:  E E Ohnhaus; A M Breckenridge; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Antipyrine metabolism is not affected by terbinafine, a new antifungal agent.

Authors:  R Seyffer; M Eichelbaum; J C Jensen; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Quantification of three lidocaine metabolites and their conjugates.

Authors:  Y K Tam; J Ke; R T Coutts; D G Wyse; M R Gray
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

7.  Preparative isolation and purification of urinary conjugates in antipyrine metabolism in man and rat.

Authors:  J Böttcher; H Bässmann; R Schüppel; W D Lehmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

8.  Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.

Authors:  S M Borcherding; T L Bastian; T H Self; N Abou-Shala; B W LeDuc; R L Lalonde
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

9.  Effect of chlormethiazole on hepatic monooxygenases activity in vivo.

Authors:  H Mönig; D J Back; H T Heidemann; E E Ohnhaus; B Brockmann; H M Schulte
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.

Authors:  M Eichelbaum; L Bertilsson; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.